Literature DB >> 23972588

Insight into illness in late-life schizophrenia: a function of illness severity and premorbid intellectual function.

Philip Gerretsen1, Benoit H Mulsant, Angela Y Liu, Eric Granholm, Mahesh Menon, Ariel Graff-Guerrero, Bruce G Pollock, David C Mamo, Tarek K Rajji.   

Abstract

Impaired insight into illness is a common but poorly understood phenomenon in schizophrenia. Several studies in midlife adults with schizophrenia have reported an association between impaired insight and illness severity, executive dysfunction, premorbid intellectual function, and to a lesser degree attention. Aging is associated with a decline in attention and executive function. Thus, the relationship between cognition and insight is expected to differ between younger and older adults with schizophrenia. This study assessed this relationship among 50 patients with schizophrenia 60 years and older. Insight was explained by illness severity (16.2% of the variance) and premorbid intellectual function (23.9% of the variance), but not by attention or executive function. Our findings suggest that the predictors of insight in schizophrenia differ early and later in life. In particular, insight's association with attention and executive function observed in younger patients is attenuated by age-related changes in cognition. In contrast, premorbid intellectual function continues to be a strong predictor of insight in late life, which highlights the need to better understand and enhance cognitive function early in the course of schizophrenia.
© 2013.

Entities:  

Keywords:  Aging; Cognition; Illness awareness; Insight; Schizophrenia

Mesh:

Year:  2013        PMID: 23972588     DOI: 10.1016/j.schres.2013.07.025

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

Review 1.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

2.  Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies.

Authors:  Nicole Meade; Lily Shi; Stine R Meehan; Catherine Weiss; Zahinoor Ismail
Journal:  J Psychopharmacol       Date:  2020-07-10       Impact factor: 4.153

3.  Delusional Disorder over the Reproductive Life Span: The Potential Influence of Menopause on the Clinical Course.

Authors:  Alexandre González-Rodríguez; Oriol Molina-Andreu; Rafael Penadés; Marina Garriga; Alexandre Pons; Rosa Catalán; Miguel Bernardo
Journal:  Schizophr Res Treatment       Date:  2015-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.